Brief: Vyant Bio Reports Quarterly Results
March 30 (Reuters) - Vyant Bio Inc VYNT.O :
* VYANT BIO REPORTS FOURTH QUARTER AND YEAR-END 2021 RESULTS
AND
PROVIDES STRATEGIC AND BUSINESS HIGHLIGHTS
* VYANT BIO INC - CASH POSITION AT DECEMBER 31, 2021 WAS
$20.6
MILLION
Source text for Eikon: ID:nGNX5pVXgt
Further company coverage: VYNT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vyant Bio
See all newsBrief: Vyant Bio Provides Update On Winddown Activities
Brief: Vyant Bio Announces Stockholder Approval Of Plan Of Dissolution
Brief: Vyant Bio Files Form 15 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Filing Of Form 25 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Voluntary Nasdaq Delisting, SEC Deregistration